Hypoactive sexual desire disorder (HSDD) affects about 30% of women and 15%
of men.
Researchers from Imperial College London in the United Kingdom say the
hormone kisspeptin could be used to treat HSDD.
Scientists found that kisspeptin helps improve sexual brain processing,
boosting sexual responses in both men and women with low sex drive.
Hypoactive sexual desire disorder (HSDD) — where a person has an extremely
low sex drive that causes them distress — affects about 30% of women and
15% of men.Treatment options for HSDD include psychotherapy, sex therapy, lifestyle
changes, medications, and hormonal therapies.Adding to these choices, researchers from Imperial College London in the
United Kingdom say the hormone kisspeptin could be used to treat HSDD by
boosting their sexual response.
of men.
Researchers from Imperial College London in the United Kingdom say the
hormone kisspeptin could be used to treat HSDD.
Scientists found that kisspeptin helps improve sexual brain processing,
boosting sexual responses in both men and women with low sex drive.
Hypoactive sexual desire disorder (HSDD) — where a person has an extremely
low sex drive that causes them distress — affects about 30% of women and
15% of men.Treatment options for HSDD include psychotherapy, sex therapy, lifestyle
changes, medications, and hormonal therapies.Adding to these choices, researchers from Imperial College London in the
United Kingdom say the hormone kisspeptin could be used to treat HSDD by
boosting their sexual response.
